Expert Ratings for Karyopharm Therapeutics
Analysts assigned the following ratings to Karyopharm Therapeutics KPTI during the last quarter:
These 4 analysts have an average price target of $11.75 from Karyopharm Therapeutics' current price of $5.2, implying upside.
Below is a summary of how these 4 analysts have rated Karyopharm Therapeutics over the past 3 months. The higher the number of bullish ratings, the more analysts are positive on the security and the higher the number of bearish ratings, the more analysts are negative on the security
This current average represents a 24.19% decline from the previous average price target of $15.50.
If you want to follow small cap stock news and performance, you can start by following it here.
Analysts work in banking and financial systems and typically specialize in reporting on stocks or defined industries. Analysts can attend company conference calls and meetings, research company financials, and communicate with insiders to issue "analyst notes" for stocks. Analysts typically rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and industry analysts are also human and only offer their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Analysts assigned the following ratings to Karyopharm Therapeutics KPTI during the last quarter:
These 4 analysts have an average price target of $11.75 from Karyopharm Therapeutics' current price of $5.2, implying upside.
Below is a summary of how these 4 analysts have rated Karyopharm Therapeutics over the past 3 months. The higher the number of bullish ratings, the more analysts are positive on the security and the higher the number of bearish ratings, the more analysts are negative on the security
This current average represents a 24.19% decline from the previous average price target of $15.50.
If you want to follow small cap stock news and performance, you can start by following it here.
Analysts work in banking and financial systems and typically specialize in reporting on stocks or defined industries. Analysts can attend company conference calls and meetings, research company financials, and communicate with insiders to issue "analyst notes" for stocks. Analysts typically rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and industry analysts are also human and only offer their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
What's Your Reaction?
